13F HOLDINGS REPORT
Avoro Capital Advisors LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001104659-26-015748
Total Value
$10.17B
Positions
34
Other Managers
0
Confidential Omitted
No
Holdings (34)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP | UTHR | 2,606,060 | $1.27B | 12.48% |
| 2 | ASCENDIS PHARMA | ASND | 5,111,111 | $1.09B | 10.71% |
| 3 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,807,500 | $1.05B | 10.35% |
| 4 | ARGENX SE | ARGX | 990,000 | $832.5M | 8.18% |
| 5 | KRYSTAL BIOTECH INC | KRYS | 2,888,888 | $712.2M | 7.00% |
| 6 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 10,625,000 | $705.4M | 6.93% |
| 7 | KYMERA THERAPEUTICS INC | KYMR | 7,474,747 | $581.6M | 5.72% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 6,555,555 | $455.9M | 4.48% |
| 9 | AVIDITY BIOSCIENCES INC | 05370A108 | 5,455,000 | $393.5M | 3.87% |
| 10 | CENTESSA PHARMACEUTICALS PLC | CNTA | 14,555,555 | $364.0M | 3.58% |
| 11 | CELCUITY INC | CELC | 3,111,111 | $310.3M | 3.05% |
| 12 | APELLIS PHARMACEUTICALS INC | APLS | 12,222,222 | $307.0M | 3.02% |
| 13 | VERA THERAPEUTICS INC | VERA | 5,888,888 | $298.2M | 2.93% |
| 14 | SPDR SERIES TRUST - S&P BIOTECH | 78464A870 | 2,100,000 | $256.1M | 2.52% |
| 15 | XENON PHARMACEUTICALS INC | XENE | 5,424,444 | $243.1M | 2.39% |
| 16 | TERNS PHARMACEUTICALS INC | TERN | 4,350,000 | $175.7M | 1.73% |
| 17 | REVOLUTION MEDICINES INC | RVMDW | 2,170,000 | $172.8M | 1.70% |
| 18 | UNIQURE NV | QURE | 6,150,000 | $147.2M | 1.45% |
| 19 | SOLENO THERAPEUTICS INC | SLNO | 2,900,000 | $134.3M | 1.32% |
| 20 | OCULAR THERAPEUTIX INC | OCUL | 10,777,777 | $130.8M | 1.29% |
| 21 | TAYSHA GENE THERAPIES INC | TSHA | 21,700,000 | $119.3M | 1.17% |
| 22 | MIND MEDICINE (MINDMED) INC | 60255C885 | 5,000,000 | $67.0M | 0.66% |
| 23 | PTC THERAPEUTICS INC | PTCT | 685,000 | $52.0M | 0.51% |
| 24 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,500,000 | $46.7M | 0.46% |
| 25 | ORUKA THERAPEUTICS INC | ORKA | 1,333,340 | $40.4M | 0.40% |
| 26 | ALKERMES PLC | ALKS | 1,400,000 | $39.2M | 0.39% |
| 27 | APOGEE THERAPEUTICS INC | APGE | 500,000 | $37.7M | 0.37% |
| 28 | SEPTERNA INC | SEPN | 1,337,500 | $37.3M | 0.37% |
| 29 | LEXEO THERAPEUTICS INC | LXEO | 3,300,000 | $32.8M | 0.32% |
| 30 | MANNKIND CORP | MNKD | 4,444,444 | $25.2M | 0.25% |
| 31 | GH RESEARCH PLC | GHRS | 1,800,000 | $22.9M | 0.22% |
| 32 | INCYTE CORP | INCY | 135,000 | $13.3M | 0.13% |
| 33 | WHITEHAWK THERAPEUTICS INC | WHWK | 2,849,402 | $6.9M | 0.07% |
| 34 | ASCENDIS PHARMA | ASND | 50,000 | $625,000 | 0.01% |